Communication is a fundamental factor for innovation. In the area of oncology, communication between scientists and physicians can pave the way for new treatment options to become breakthroughs. Research endeavors for new substances that are as effective as possible also support these efforts.
Interdisciplinary exchange of experience is a central topic. The Sarcoma Network Knowledge Platform for Scientists aims to support this exchange of information and motivate scientists and physicians to share their experiences in the interest of affected patients. This website project was initiated by PharmaMar. It was created to support the Swiss Sarcoma Board’s initiative and to document specific projects to complement the Board’s efforts.
Founded in 1986, PharmaMar is a biopharmaceutical company determined to advance cancer treatment through discovering, developing, producing, and marketing innovative drugs of marine origin.
The company has a unique marine organism library containing over 155,000 specimens. PharmaMar’s Research, Development, and Innovation Department has discovered 700 new chemical entities and identified 30 new families of compounds. As a result of this work, PharmaMar has over 1800 patents that either have been awarded or are in the processing stage.
PharmaMar’s employees are part of a global network of excellence, in which over 60 research centres and universities worldwide collaborate to find new discoveries in marine biology, chemistry, and cancer biology.
Over 12,000 patients with different types of cancer, at over 200 hospitals worldwide, have benefited from treatment with PharmaMar’s compounds.
Here you will find links to other websites in Switzerland and other countries that are also actively committed to research, medicine and interdisciplinary communication in particular medical specialties.
The Swiss National Sarcoma Advisory Board unites all physicians, researchers and allied health staff in Switzerland to focus on improving the survival of sarcoma patients. There are two Board meetings a year, where all decisions are taken. It determines the „Ausschuss“ as well as the working groups. The Advisory Board represents the common platform of all sarcoma centers.
The Zurich Sarcoma Center offers patients with musculoskeletal tumors interdisciplinary care covering all areas of treatment.
The Sarcoma Center at the Bern University Hospital offers patients with musculoskeletal tumors interdisciplinary care covering all areas of treatment including registration services. The Sarcoma Center at the Bern University Hospital also provides a weekly Sarcoma Board for doctors. All relevant information is available on the website.
The Connective Tissue Oncology Society was formed in 1995 and incorporated in 1997. CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors and to increase knowledge of all aspects of the biology of these tumors, including basic and clinical research.
Founded in 1986, PharmaMar is a biopharmaceutical company with headquarters in Madrid (Spain), determined to advance cancer treatment through discovering, developing, producing, and marketing innovative drugs of marine origin.